Create account

Coverage dated October 21, 2026 to October 24, 2026

Nationwide recall on these compound GLP-1 drugs

Headline from WOWK Charleston

The compounded GLP-1s are not FDA-approved nor name-brand.

WOWK Charleston's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.

Read the reports

Reports & sources

25 articles, oldest first.

  1. The Boston Globe

    Compounded GLP-1 drugs recalled amid rising concerns over unapproved weight-loss alternatives (opens The Boston Globe)

    Published

    The Boston Globe's feed description

    The FDA officially warned patients not to use compounded GLP-1s this month unless an individual’s medical needs cannot be met by approved name-brand drugs.

  2. WOWK Charleston

    Nationwide recall on these compound GLP-1 drugs (opens WOWK Charleston)

    Published

    WOWK Charleston's feed description

    The compounded GLP-1s are not FDA-approved nor name-brand.

Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.

Related updates

Separate coverage close to this update in time and subject.